These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3251508)

  • 1. Partial reversal of the iminodipropionitrile-induced hyperkinetic syndrome in rats by alpha-tocopherol (vitamin E).
    Lohr JB; Cadet JL; Wyatt RJ; Freed WJ
    Neuropsychopharmacology; 1988 Dec; 1(4):305-9. PubMed ID: 3251508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentoxifylline attenuates iminodipropionitrile-induced behavioral abnormalities in rats.
    Al Kadasah S; Al Mutairy A; Siddiquei M; Khan HA; Abdulwahid Arif I; Al Moutaery K; Tariq M
    Behav Pharmacol; 2009 Jul; 20(4):356-60. PubMed ID: 19584713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of selenium and vitamin E on iminodipropionitrile induced dyskinesia in rats.
    Tariq M; al-Deeb S; al-Moutairy K; Mujeebuddin S; Arshaduddin M; Bruyn GW
    Int J Neurosci; 1994 Oct; 78(3-4):185-92. PubMed ID: 7883455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dipyridamole attenuates the development of iminodipropionitrile-induced dyskinetic abnormalities in rats.
    Tariq M; al-Deeb S; al-Moutaery K; Bruyn GW; Evans DA; Arshaduddin M
    Brain Res Bull; 1995; 38(1):31-5. PubMed ID: 7552372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cysteamine attenuates iminodipropionitrile (IDPN) induced dyskinesia in rats.
    Tariq M; Al-Deeb S; Al-Moutairy K; Ahmad Khan H
    Int J Neurosci; 1995 Dec; 83(3-4):165-75. PubMed ID: 8869425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of iminodipropionitrile induced behavioral syndrome by sodium salicylate in rats.
    Tariq M; Khan HA; Al Moutaery K; Al Deeb S
    Pharmacol Biochem Behav; 2002 Oct; 73(3):647-54. PubMed ID: 12151040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonidine and prazosin block the iminodipropionitrile (IDPN)-induced spasmodic dyskinetic syndrome in mice.
    Cadet JL; Braun T; Freed WJ
    Pharmacol Biochem Behav; 1987 Apr; 26(4):791-5. PubMed ID: 3037570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proglumide, a cholecystokinin receptor antagonist, exacerbates beta, beta'-iminodipropionitrile-induced dyskinetic syndrome in rats.
    Tariq M; Khan HA; Rehana Z; Al Moutaery K; Al Deeb S
    Neurotoxicol Teratol; 1998; 20(5):571-9. PubMed ID: 9761597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-lasting effect of ceruletide on dyskinesia and monoaminergic neuronal pathways in rats treated with iminodipropionitrile.
    Ogawa N; Haba K; Asanuma M; Mori A
    Brain Res; 1991 Aug; 556(2):271-9. PubMed ID: 1933361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of hydrocortisone on iminodipropionitrile-induced neurotoxicity in rats.
    Tariq M; Khan HA; Siddiquei MM; Al Moutaery K; Al Deeb S
    Basic Clin Pharmacol Toxicol; 2007 Mar; 100(3):176-81. PubMed ID: 17309521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of repeated cyclosporin A administration on iminodipropionitrile-induced dyskinesia and TRE-/CRE-binding activities in rat brain.
    Iida K; Iwata E; Asanuma M; Asanuma SN; Gómez-Vargas M; Miyazaki I; Nakanishi T; Ogawa N
    Neurosci Res; 1998 Feb; 30(2):185-93. PubMed ID: 9579652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone inhibits the persistent spasmodic dyskinesia induced by chronic intraperitoneal administration of iminodipropionitrile (IDPN).
    Cadet JL; Braun TL
    Neuropeptides; 1986 Jul; 8(1):87-91. PubMed ID: 3762878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance to beta,beta'-iminodipropionitrile (IDPN)-induced neurobehavioural and vestibular toxicity in diabetic rats.
    Tariq M; Khan HA; Moutaery KA; Deeb SA
    J Appl Toxicol; 1999; 19(2):93-9. PubMed ID: 10215181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide synthase inhibitor aminoguanidine potentiates iminodipropionitrile-induced neurotoxicity in rats.
    Tariq M; Khan HA; Al Deeb S; Al Moutaery K
    Neurosci Lett; 1999 Nov; 276(1):49-52. PubMed ID: 10586972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotransmitter and receptor alterations in the rat persistent dyskinesia model induced by iminodipropionitrile.
    Ogawa N; Mizukawa K; Haba K; Sato H
    Eur Neurol; 1990; 30 Suppl 1():31-40. PubMed ID: 1968833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iminodipropionitrile-induced dyskinesia in mice: striatal calcium channel changes and sensitivity to calcium channel antagonists.
    Bangalore R; Hawthorn M; Triggle DJ
    J Neurochem; 1991 Aug; 57(2):550-5. PubMed ID: 1649253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cortical serotonin-2 (5-HT-2) receptors in the iminodipropionitrile (IDPN)-model of persistent dyskinesia in the rat.
    Cadet JL; Rothman RB
    Neuropeptides; 1987; 10(2):175-80. PubMed ID: 3683772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced neurotoxicity of 3,3'-iminodipropionitrile following carbon tetrachloride pretreatment in the rat.
    Llorens J; Crofton KM
    Neurotoxicology; 1991; 12(3):583-94. PubMed ID: 1745441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sodium benzoate attenuates iminodipropionitrile-induced behavioral syndrome in rats.
    Tariq M; Khan HA; Al Moutaery K; Al Deeb S
    Behav Pharmacol; 2004 Dec; 15(8):585-8. PubMed ID: 15577457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-nitro-L-arginine, a nitric oxide synthase inhibitor, aggravates iminodipropionitrile-induced neurobehavioral and vestibular toxicities in rats.
    Khan HA
    Exp Toxicol Pathol; 2012 Nov; 64(7-8):791-6. PubMed ID: 21388795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.